Quilter Reports AuMA Of GBP 107.2 Bln At End Of March 2022

By RTTNews Staff Writer ✉ | Published: 4/20/2022 3:03 AM ET

Quilter plc, formerly known as Old Mutual Wealth Management Limited, reported Assets under Management and Administration or "AuMA" of 107.2 billion pounds at the end of March 2022, a decline of 4% from 31 December 2021.

The company said that average AuMA for the first quarter of 107.6 billion pounds was modestly ahead of 2021 full year average of 105.3 billion pounds.

Net inflows was 1.0 billion pounds despite the volatile market backdrop, representing 4% of opening AuMA annualized.

Annualised gross flow per adviser was up 14% to 2.5 million pounds.

For comments and feedback contact: editorial@rttnews.com

Business News

Biotech Stocks Facing FDA Decision In March 2023

Biotech Stocks Facing FDA Decision In February 2023

Biotech stocks Facing FDA Decision in January 2023

Editors Pick

United Airlines, Archer To Launch First Air Taxi Route In Chicago

United Airlines and Archer Aviation Inc. announced plans to launch the first commercial electric air taxi route in Chicago, between O'Hare International Airport or ORD and Vertiport Chicago. As part of their urban air mobility or UAM network buildout, both companies will utilize Archer's electric vertical takeoff and landing or eVTOL aircraft in the new route.

Aunt Millie's Our Family White Hot Dog Buns Recalled

Fort Wayne, Indiana-based Perfection Bakeries D/B/A Aunt Millie's is recalling 8 ct. packages of Our Family White Hot Dog Buns citing the possible presence of undeclared sesame, a known allergen, the U.S. Food and Drug Administration said. The product comes in a printed plastic package marked with "Our Family Hot Dog Buns 8 ct." on the top and has a blue twist tie.

Ascend Labs Recalls Oral Anticoagulant Dabigatran Etexilate Capsules

Parsippany, New Jersey -based Ascend Laboratories LLC. is recalling Dabigatran Etcxilate capsules citing the detection of N-Nitrosodimethylamine or NDMA impurity, a probable human carcinogen, the U.S. Food and Drug Administration said. The product is used as an oral anticoagulant to lower the risk of stroke and blood clots.